# V1 Empirics Check — x-ai/grok-4.1-fast (Variant C)

**Model:** x-ai/grok-4.1-fast
**Variant:** C
**Date:** 2026-03-26T10:17:06.386916

---

### 1. Idea Fidelity
The paper deviates substantially from the original idea manifest. The core research question—SNAP recertification intensity increasing Medicaid *claims* volatility (via T-MSIS CV, beneficiary count volatility, claims-per-beneficiary volatility, and claims gap indicators) through bureaucratic competition in integrated eligibility states (IES)—is reframed to *enrollment* volatility using aggregate CMS reports, not T-MSIS. Key identification elements are partially retained (DiD interacting continuous recertification intensity with IES status; state/month FEs; COVID waivers as natural experiment; placebo on non-IES), but the primary/secondary/tertiary outcomes, T-MSIS/NPPES data linkage, dose-response with SNAP caseload, and behavioral health claims are entirely absent. The 36-month (2018–2020) overlap and 1,836 observations are misreported as 3,621, undermining feasibility claims. This pivot weakens the "ripple" mechanism (claims gaps from processing lapses) and novel contribution (quantifying spillover to claims via shared IT/caseworkers).

### 2. Summary
This paper estimates how SNAP recertification intensity (share on ≤6-month cycles) spills over to increase month-over-month Medicaid *enrollment* volatility in 26 IES states relative to 25 non-IES states, using a state-month DiD (2018–2020). The interaction coefficient (2.38, implying a 0.24 pp rise per 10 pp treatment increase, or 30% of mean volatility) is interpreted as administrative contagion overwhelming a "reminder" channel (negative main effect in non-IES states). Robustness includes pre-COVID subsample, randomization inference (p=0.022), and heterogeneity by expansion status, with standardized effects labeled "large" (>1 SD).

### 3. Essential Points
1. **Outcome and data mismatch undermines mechanism and novelty**: The manifest explicitly targeted T-MSIS claims volatility (CV, gaps >10%, behavioral health H-codes) to capture "claims adjudication delays or eligibility lapses visible as claims gaps," but the paper substitutes aggregate enrollment volatility (|Δ% month-over-month| from CMS reports). Enrollment aggregates genuine eligibility changes with administrative churn, diluting the "bureaucratic resource competition" story (e.g., IT backlogs delaying *claims*, not just headcounts). No justification for this switch; reinstate T-MSIS or explicitly defend why enrollment proxies claims volatility (e.g., via correlation table). Absent this, the spillover claim is unsubstantiated, and cross-program novelty evaporates.

2. **Inconsistent sample size and period reporting**: Data section claims Jan 2018–Dec 2020 (36 months × 51 states = 1,836 obs), but Table 1 reports 3,621 obs (∼71 months), with IES/non-IES splits (1,846/1,775) summing correctly to 3,621 but contradicting manifest feasibility (1,836 obs) and pre-COVID (2,601 obs, ∼51 months). Mechanism Table drops to 3,504/2,434/1,187 obs without explanation. Fix counts precisely (e.g., confirm exact months, handle missingness); this error alone invalidates summary stats, variation claims, and power assessments.

3. **Implausibly large magnitudes with inadequate parallel trends validation**: The β₂=2.38 (SE=0.20) implies a 1.03 SD increase in volatility per SD treatment shift—economically massive (3,100 extra disrupted beneficiaries/state/month on 1.3M base), yet unexplained why IES states (slightly lower mean intensity: 0.33 vs. 0.38) show such sensitivity. No event study or pre-trends plot tests parallel trends in volatility by future IES status or intensity quartiles; DiD assumptions fail without this (especially with time-invariant IES and volatile outcomes, SD(Y)=1.02). Effects survive pre-COVID but COVID "natural experiment" is mentioned but not executed (e.g., no triple-difference on waiver timing).

These flaws prevent a clear, credible result; address or reject for AER: Insights.

### 4. Suggestions
**Strengthen identification and threats**:
- Add an event-study DiD: Plot coefficients on leads/lags of ΔRecertIntensity × IES (bin intensity changes into quantiles for power). Use pre-2018 data if available from SNAP Policy DB (manifest notes 1996–2020) to extend pre-period and test trends.
- Fully leverage COVID waivers: Estimate a triple interaction (Post-March2020 × Intensity × IES) or diff-in-diff-in-diff (IES as "treated," non-IES as control, waiver as shock). Quantify "pressure evaporation" by interacting waiver with pre-policy intensity.
- Placebo outcomes/tests: Beyond non-IES restriction, test on SNAP-unrelated volatility (e.g., Medicare enrollment from CMS; state unemployment volatility). Permute *intensity* (not just IES) in RI for continuous treatment.

**Refine empirics and magnitudes**:
- Standard errors are appropriately clustered (state, N=51), but report wild cluster bootstrap (Cameron et al. 2008) or state-level randomization inference p-values separately by spec (current table lumps under all columns). With small N, power is high for large effects—simulate minimum detectable effect (e.g., via simulations with SD(X)=0.44, SD(Y)=1.02).
- Magnitudes are plausible directionally (contagion vs. reminder) but huge; decompose volatility into components (e.g., regress |ΔEnroll| on enrollment level to partial out scale effects). Report confidence intervals for economic impacts (e.g., 95% CI on 3,100 beneficiaries). Standardized effects (App. Table 3) use |SDE|>0.15 as "large," but justify threshold (cite conventions like Chingos et al. 2012 for policy effects).
- Alternative intensity measures: Manifest's 18 variables (mean/median/distribution by household type)—test dose-response by quintiles or PCA; col (3) alternative (avg. period) is good, but add interactions with SNAP caseload (manifest feasibility).

**Data and outcomes**:
- Bridge to manifest: Compute T-MSIS claims volatility as secondary outcome (even aggregated state-month CV aligns with "READY" smoke test: IES CV=0.105 vs. 0.102). Join CMS enrollment to T-MSIS beneficiary counts for claims-per-enrollee volatility.
- Expand mechanism: Log applications ↑ in IES (col1, β₂=0.74) contradicts backlog theory (should ↓ processing); reframe as "induced applications from reminders" or test delays (e.g., apps-to-enrollment lag). Add controls (e.g., state budget for admin from NASBO; Medicaid renewal intensity).
- Summary stats: Balance table by intensity quartiles (IES vs. non-IES); plot raw series (e.g., volatility vs. intensity binned by IES).

**Writing and presentation**:
- Abstract/intro: Tone down "stark" claims until trends validated; quantify reminder channel precisely (net effect in IES: β₁ + β₂ ≈0.7, still ↑ volatility).
- Tables: Add N states per column; stars consistent but p<0.001 overkill (report exact). Landscape for robustness if crowded.
- Heterogeneity: Nice expansion split; add by SNAP caseload size terciles (manifest) or admin capacity proxies (caseworkers/1K enrollees).
- Limitations: Good; add omitted variable bias formula (e.g., Altonji et al. 2005 ratio using non-IES gradient).
- Overall: Tight AER:I format; with fixes (esp. trends, data consistency, T-MSIS), novel spillover + reminder nuance could shine. Simulate revisions' power first.

This positions the paper strongly if executed—clear policy lever (SNAP rules as health tool) amid $1T+ stakes.
